Pfizer Inc. (NYSE:PFE) proposed buying AstraZeneca Plc (AZN) for about 58.8 billion pounds ($98.7 billion) and is still interested in a deal after the U.K. company spurned the offer. Pfizer Inc. (NYSE:PFE) shares after opening at $30.73 moved to $30.80 on last trade day and at the end of the day closed at $30.75 . Company price to sales ratio in past twelve months was calculated as 3.81 and price to cash ratio as 6.07. Pfizer Inc. (NYSE:PFE) showed a positive weekly performance of 1.65%.
AstraZeneca plc (ADR) (NYSE:AZN) released its earnings data on Thursday. The company reported $1.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by $0.06, Analyst Ratings.Net reports. The company had revenue of $6.42 billion for the quarter, compared to the consensus estimate of $6.32 billion. AstraZeneca plc (ADR) (NYSE:AZN) shares fell -0.51% in last trading session and ended the day on $68.66. AZN return on equity ratio is recorded as 19.10% and its return on assets is 8.10%. AstraZeneca plc (ADR) (NYSE:AZN) yearly performance is 40.64%.
Barclays PLC (ADR) (NYSE:BCS) has faced intense scrutiny in recent weeks over its decision to increase the bonus pool for last year even as the bank had a steep loss in the fourth quarter. Barclays PLC (ADR) (NYSE:BCS) shares moved down -0.83% in last trading session and was closed at $16.79 while trading in range of $16.70 – $16.90 – Barclays PLC (ADR) (NYSE:BCS) year to date (YTD) performance is -6.15%.
National Bank of Greece (ADR) (NYSE:NBG) was upgraded by equities research analysts at BofA Merrill Lynch from an “underperform” rating to a “neutral” rating in a research note issued to investors on Wednesday, AR Network reports. National Bank of Greece (ADR) (NYSE:NBG) weekly performance is -10.04%. On last trading day company shares ended up $4.03. National Bank of Greece (ADR) (NYSE:NBG) distance from 50-day simple moving average (SMA50) is -20.25%. Analysts mean target price for the company is $4.65.
Leave a Reply